Results 141 to 150 of about 690,948 (299)

Recipient–Donor Sex Combinations and Posttransplant Infections: A Swiss Transplant Cohort Study

Transplant Infectious Disease, EarlyView.
In this cohort study of 5033 patients, only the recipient sex, in particularly kidney recipients, was independently associated with an increased risk of infections, when compared to males. These findings indicate that recipient–donor sex combination does not influence short‐term solid organ transplantation outcome.
Christian T. J. Magyar, Charlene P. Gretener, Jaromil Frossard, Katell Mellac, Daniel Sidler, David Reineke, Nicolas J. Mueller, Franz Immer, Christian van Delden, Oriol Manuel, Thorsten Krueger, Nina Khanna, Katia Boggian, Lara Beekman, Cédric Hirzel, Vanessa Banz, Swiss Transplant Cohort Study (STCS)   +16 more
wiley   +1 more source

Optimizing Pneumocystis jirovecii Prophylaxis in Immunocompromised Patients: Defining the Clinical Role of Atovaquone

Transplant Infectious Disease, EarlyView.
In a retrospective cohort study of 149 patients receiving atovaquone for PJP prophylaxis, increased usage was related to broader indications, uptake in new patient groups, difficulty tolerating or accessing alternatives, and longer durations used per patient.
To N. Pham, Kelly A. Cairns, Adithi Ramachandra, Susan G. Poole, Carmela E. Corallo, Bradley J. Gardiner   +5 more
wiley   +1 more source

Cross-kingdom microbiome interactions along the gut-lung axis: immune-microecological coordination, shared mechanisms, and disease-context dependence in respiratory disorders. [PDF]

Gut Microbes
Yu J, Meng J, Shi Z, Zou J, Lai Z.
europepmc   +1 more source

Incidental Detection of Respiratory Viruses in Lung Transplant Donor‐Recipient Pairs: Exploratory Associations With Clinical Outcomes in a Post Hoc Analysis

Transplant Infectious Disease, EarlyView.
In 53 lung transplant donor‐recipient pairs, community‐acquired respiratory viruses were incidentally detected by syndromic PCR in 13.2% of donor and 20.8% of recipient bronchoalveolar lavages, with exploratory, unadjusted signals towards longer hospitalization and chronic lung allograft dysfunction.
Andrea Lombardi, Letizia Corinna Morlacchi, Giulia Renisi, Lorenzo Rosso, Jacopo Fumagalli, Patrizia Bono, Ilaria Righi, Valeria Rossetti, Arianna Liparoti, Cecilia Azzarà, Davide Mangioni, Laura Alagna, Anna Celotti, Claudia Alteri, Chiara Abbruzzese, Annapaola Callegaro, Francesco Blasi, Giacomo Grasselli, Mario Nosotti, Alessandra Bandera   +19 more
wiley   +1 more source

Lung Microbiome Diversity, Infection Dynamics, and Microbe-Mediated Cross-Protection. [PDF]

Microbiologyopen
Arooj S, Zubair A, Batool SZ, Niaz G, Ali M, Waheed Y, Elsharkawy ER, Afghan N.   +7 more
europepmc   +1 more source

From Surviving to Thriving: Overcoming Early Career Challenges in Transplant Infectious Diseases

Transplant Infectious Disease, EarlyView.
Practical strategies to overcome early‐career challenges in transplant infectious diseases are presented, emphasizing mentorship, focused expertise, collaboration, and sustainability. Long‐term success depends on aligning effort, opportunity, and collaboration over time. ABSTRACT Transplant infectious diseases (TID) is a highly specialized subspecialty
Courtney E. Harris, Chelsea A. Gorsline, Ruth Adekunle, Christina Vojtek, Eric Altneu, Julia Bini Viotti, Michael Scolarici, Chia‐Yu Chiu, Rebecca N. Kumar   +8 more
wiley   +1 more source

Animal models of fungus-related allergic airway disease: exposures, readouts, mechanisms, and translational gaps. [PDF]

Front Cell Infect Microbiol
Qu Y, Du R, Liu P, Pan Y, Zhi L, Gao Y, Qi Q.   +6 more
europepmc   +1 more source

Pulmonary and sinus fungal diseases in non-immunocompromised patients.

Lancet. Infectious Diseases (Print), 2017
D. Denning, A. Chakrabarti
semanticscholar   +1 more source

Impact of Letermovir on Voriconazole Concentrations in Lung Transplant Patients

Transplant Infectious Disease, EarlyView.
Concomitant letermovir was associated with lower voriconazole exposure and reduced attainment of commonly used efficacy thresholds in lung transplant recipients. Routine therapeutic drug monitoring after letermovir initiation is recommended, and empiric voriconazole dose escalation may be needed to avoid subtherapeutic exposure. ABSTRACT Background The
Leah Georgiades, Sunish Shah, Erin K. McCreary, Fernanda Silveira, Raman Venkataramanan, Vignesh Vasudevan, Ryan M. Rivosecchi   +6 more
wiley   +1 more source

Editorial: Deciphering the microbiome's role in the progression of interstitial lung diseases. [PDF]

Front Med (Lausanne)
Carbone RG, Russell AM.
europepmc   +1 more source